Validation of two stable isotopic labels for determination of albumin synthesis rate
Completed
- Conditions
- liver function / liver failureMetabolic and Endocrine - Other metabolic disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12614000541606
- Lead Sponsor
- Jan Wernerman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
healthy volunteers
Exclusion Criteria
Age < 18 years
Participation in other trial within 2 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method albumin synthesis rate<br><br>Albumin fractional synthesis rate is assessed by the flooding technique (Ballmer et al Am J Physiol 1990; 259: E797-803). The incorporation of labeled phenylalanine in plasma albumin is assessed by gas chromatography-mass spectrometry after separating albumin from other plasma proteins. The precursor pool is assessed from the ratio of labeled to unlabeled phenylalanine in plasma. [In the morning after start of infusion on each study occation. Volunteers will be studied twice (protocol 1) on day 1 and 3, or thrice on day 1, after 5 hrs and after 7 days (protocol 2).]
- Secondary Outcome Measures
Name Time Method Fibrinogen synthesis rate<br><br>Fibrinogen fractional synthesis rate is assessed by the flooding technique (Ballmer et al Am J Physiol 1990; 259: E797-803). The incorporation of labeled phenylalanine in plasma fibrinogen is assessed by gas chromatography-mass spectrometry after separating fibrinogen from other plasma proteins. The precursor pool is assessed from the ratio of labeled to unlabeled phenylalanine in plasma. [In the morning after start of infusion on each study occation. Volunteers will be studied twice (protocol 1) on day 1 and 3, or thrice on day 1, after 5 hrs and after 7 days (protocol 2).]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie albumin synthesis rate measurement using d5-phenylalanine versus d8-phenylalanine in liver function studies?
How do isotopic labeling techniques compare to standard methods for assessing hepatic protein synthesis in metabolic disorders?
Which biomarkers correlate with albumin synthesis rates in patients with chronic liver failure or gastrointestinal diseases?
What adverse events are associated with intravenous isotopic amino acid infusions in healthy volunteers and how are they managed?
Are there alternative stable isotope compounds to d5/d8-phenylalanine for evaluating hepatic synthetic capacity in clinical trials?